Awshad Launches 6500 mg CBD Oil for Chronic Pain Relief

Awshad, a medical cannabis wellness startup that is situated at the forefront of the field, has launched its most potent CBD oil ever with a concentration of 6500 mg aimed to be the relief from chronic pain, cancer, epilepsy, severe anxiety & insomnia.

The celebration of this event marks the fourth year since the establishment of Awshad, thereby, indicating the historicity of the Mumbai-based company's success in the medical cannabis market in India.

Over the last three years, the trajectory of Awshad has changed it from a startup of little-known niche into a major player in wellness whose product portfolio ranges from CBD oils to capsules, gummies, mushroom supplements, and pet wellness products.

The company has more than 10,000 customers, the millennial group comprising the major portion of all the consumers, and has gotten 20 times bigger than the day it was founded. The metro cities are major markets but the city like Jaipur and Indore are becoming more and more popular as markets.

Also Read: Deepak Nitrite Inaugurates World-Class R&D Centre in Vadodara

Shivam Singhee, CEO & co-founder, conveyed, "Our 6500 mg CBD oil is a landmark in the redefinition of wellness in India. Our ability to be profitable is a reflection of the harmony between our product and the market needs and the faith that we have instilled in the market. We see a very bright future for the industry with this high concentration formula at hand."

Richa Jaggi, co-founder & CMO, also mentioned, "The next stage of our development is to expand the company and work with professionals in the medical, academic, and regulatory fields to introduce wellness products based on CBD to the public."